Home › Trial NCT05453669
Clinical Study of the Efficacy of CD19-CAR-DNT Cells in the Treatment of Relapsed/Refractory B-cell NHL
- Trial IDNCT05453669
- StatusUnknown
- PhasePhase 1
- Study typeInterventional
- SponsorSecond Affiliated Hospital, Zhejiang University, School of Medicine
- Enrollment12
- Start date2022-06-15
- ConditionsB-cell Non-Hodgkin's Lymphoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.